These innovative treatments , including Rybelsus, belong to a group of drugs called GLP-1 receptor agonists . Initially developed for controlling diabetes mellitus , they function by helping the organism to secrete sufficient the hormone insulin and curbing excessive glucose levels. Additionally , their potential to support slimming has led to subs